-
Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run
19 Oct 2025 04:57 GMT
Gilead Sciences (GILD) is a top-performing … GILD, citing solid fundamentals, positive earnings momentum, and sector-leading technical … Q3 earnings.
Sundry Photography/iStock Editorial via Getty Images Gilead Sciences (NASDAQ …
-
US close: Dow Jones retreats from record highs as US-China tensions flare
22 Oct 2025 22:36 GMT
… while Netflix's quarterly earnings missed Wall Street estimates due … as Wednesday morning's earnings updates were, AT& … , but also revealed quarerly earnings had fallen short of estimates … ) $2,093.06 -2.29%
Gilead Sciences Inc. (GILD) $121.46 - …
-
Breaking Down Gilead Sciences: 6 Analysts Share Their Views
08 Oct 2025 23:33 GMT
… date on Gilead Sciences analyst ratings.
Discovering Gilead Sciences: A Closer Look
Gilead Sciences develops and … company's top-line earnings. In comparison to its industry … for key metrics such as earnings, revenue, and growth estimates. This …
-
US open: Stocks rebound as traders look past shutdown to Q3 earnings
10 Oct 2025 22:46 GMT
… key economic data releases.
Positive earnings updates from Delta Air Lines … and the beginning of Q3 earnings season, with major banks including … in June.
No major earnings were scheduled for release on … (SBUX) $80.87 1.37%
Gilead Sciences Inc. (GILD) $118.09 1 …
-
What Analysts Are Saying About Gilead Sciences Stock
16 Sep 2025 15:51 GMT
… date on Gilead Sciences analyst ratings.
Discovering Gilead Sciences: A Closer Look
Gilead Sciences develops and … company's top-line earnings. As compared to competitors, the … for helpful metrics such as earnings, revenue, and growth estimates to …
-
GILEAD SCIENCES INC (NASDAQ:GILD): A Prime Value Investing Candidate with Strong Fundamentals
13 Sep 2025 13:54 GMT
… underappreciated a company’s earnings ability or cash flow … ability, which can guard earnings and push long-term … and inherent worth over time.
Earnings Per Share (EPS) Growth: … fixes its mispricing.
Conclusion
Gilead Sciences is a significant candidate for …
-
Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty
22 Oct 2025 01:16 GMT
… that legacy Galapagos had with Gilead Sciences. Gilead retains an equity stake … moves by AstraZeneca, AbbVie, and Gilead Sciences. Each of those deals brings … company’s third-quarter 2025 earnings report in early November.
Photo …
-
Gilead Sciences, Inc. (GILD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
04 Sep 2025 18:11 GMT
Play Earnings CallPlay Earnings Call
Gilead Sciences, Inc. (NASDAQ:GILD) Wells Fargo …
-
Options Corner: Why The Market Could Be Prescribing A Bull Call Spread For Gilead Sciences
25 Aug 2025 20:50 GMT
… lesson that pharmaceutical giant Gilead Sciences, Inc. GILD learned … financial disclosure, post-earnings digestion appears to have … the second quarter, Gilead Sciences posted earnings per share of $2 … GILD Stock Options
While Gilead Sciences arguably has the …
-
Galapagos to wind down cell therapy business after failed attempt at sale
21 Oct 2025 17:13 GMT
… and a lucrative partnership with Gilead Sciences. After an initial research collaboration … when it reports third-quarter earnings in early November.